Search

everythinglearnresearchcommunity

for

Search:↓

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Stem cell niches are adaptable and key for tissue maintenance and repair.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

p14ARF and p16Ink4a cause hair follicle stem cell aging and dysfunction.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Using the drugs AMD3100 and Tacrolimus together greatly improves skin healing and hair growth after a deep skin cut by increasing stem cells in the wound.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

Intermediate filaments are crucial for cell differentiation and stem cell function.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

The 2024 guideline updates recommendations for genetic testing, imaging, and sperm retrieval in male infertility.

Targeting lipid metabolism can help treat advanced, resistant cancers.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Thymosin β4 helps improve skin healing and reduce scarring.

The peptide GHK-Cu helps heal and remodel tissue, improves skin and hair health, and has potential for treating age-related inflammatory diseases.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

A new cosmetic cream reduced facial redness and skin temperature after 4 weeks of use.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

A woman's long-term scalp issues were diagnosed as a rare skin disorder called cutaneous Langerhans cell histiocytosis.

Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

A patient with Sézary syndrome showed improvement after treatment and the study suggested follicular mucinosis might indicate future lymphoma risk.